Regenerative medicine company Orthocell has announced that it presented a paper - Cells, Scaffolds and Bioreactors for the Regeneration of Human Tendons - at the World Stem Cells and Regenerative Medicines congress in London, one of the world's leading regenerative medicine conferences.
The paper highlighted Othocell's current and future approaches to the regeneration of tendon tissue, with a particular focus on the company's recent breakthrough in demonstrating its new technology to grow human tendons outside the body.
The conference was attended by leading researchers, clinicians, companies and financiers.
Orthocell was founded in 2006 with a focus on assisting people suffering from soft tissue injuries and subsequent chronic musculoskeletal disorders.
According to the company's Managing Director, Paul Anderson, "As invited speakers at a significant global forum, we continue to demonstrate the world-leading character of our tendon regeneration work and the significant commercial interest in our mobility enhancing therapies.
"The breakthrough of growing functioning and healthy tendon outside the body was well received and positions Orthocell as one of the leading global companies in the musculoskeletal regenerative space."
He continued, "This is the second time we have been invited to present at the conference and it is a pleasure to return with more positive clinical, groundbreaking tissue engineering approaches and significant milestones achieved."